Literature DB >> 17947681

Mast cell alpha and beta tryptases changed rapidly during primate speciation and evolved from gamma-like transmembrane peptidases in ancestral vertebrates.

Neil N Trivedi1, Qiao Tong, Kavita Raman, Vikash J Bhagwandin, George H Caughey.   

Abstract

Human mast cell tryptases vary strikingly in secretion, catalytic competence, and inheritance. To explore the basis of variation, we compared genes from a range of primates, including humans, great apes (chimpanzee, gorilla, orangutan), Old- and New-World monkeys (macaque and marmoset), and a prosimian (galago), tracking key changes. Our analysis reveals that extant soluble tryptase-like proteins, including alpha- and beta-like tryptases, mastins, and implantation serine proteases, likely evolved from membrane-anchored ancestors because their more deeply rooted relatives (gamma tryptases, pancreasins, prostasins) are type I transmembrane peptidases. Function-altering mutations appeared at widely separated times during primate speciation, with tryptases evolving by duplication, gene conversion, and point mutation. The alpha-tryptase Gly(216)Asp catalytic domain mutation, which diminishes activity, is present in macaque tryptases, and thus arose before great apes and Old World monkeys shared an ancestor, and before the alphabeta split. However, the Arg(-3)Gln processing mutation appeared recently, affecting only human alpha. By comparison, the transmembrane gamma-tryptase gene, which anchors the telomeric end of the multigene tryptase locus, changed little during primate evolution. Related transmembrane peptidase genes were found in reptiles, amphibians, and fish. We identified soluble tryptase-like genes in the full spectrum of mammals, including marsupial (opossum) and monotreme (platypus), but not in nonmammalian vertebrates. Overall, our analysis suggests that soluble tryptases evolved rapidly from membrane-anchored, two-chain peptidases in ancestral vertebrates into soluble, single-chain, self-compartmentalizing, inhibitor-resistant oligomers expressed primarily by mast cells, and that much of present numerical, behavioral, and genetic diversity of alpha- and beta-like tryptases was acquired during primate evolution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947681      PMCID: PMC2366170          DOI: 10.4049/jimmunol.179.9.6072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells.

Authors:  Lawrence B Schwartz; Hae-Ki Min; Shunlin Ren; Han-Zhang Xia; Jiang Hu; Wei Zhao; George Moxley; Yoshihiro Fukuoka
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

2.  Effect of sex and haplotype on plasma tryptase levels in healthy adults.

Authors:  Hae-Ki Min; George Moxley; Michael C Neale; Lawrence B Schwartz
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

Review 3.  Tryptase genetics and anaphylaxis.

Authors:  George H Caughey
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

4.  Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.

Authors:  C Huang; L Li; S A Krilis; K Chanasyk; Y Tang; Z Li; J E Hunt; R L Stevens
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

5.  A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.

Authors:  K Sakai; S Ren; L B Schwartz
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

6.  Cloning and characterization of complementary DNA for human tryptase.

Authors:  J S Miller; E H Westin; L B Schwartz
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.

Authors:  P Vanderslice; S M Ballinger; E K Tam; S M Goldstein; C S Craik; G H Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome.

Authors:  Wilfred W Raymond; Christian P Sommerhoff; George H Caughey
Journal:  Arch Biochem Biophys       Date:  2005-03-15       Impact factor: 4.013

9.  Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study.

Authors:  W J Tremaine; A Brzezinski; J A Katz; D C Wolf; T J Fleming; J Mordenti; L C Strenkoski-Nix; M C Kurth
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

10.  The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region.

Authors:  Ulf Marquardt; Frank Zettl; Robert Huber; Wolfram Bode; Christian Sommerhoff
Journal:  J Mol Biol       Date:  2002-08-16       Impact factor: 5.469

View more
  16 in total

Review 1.  Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.

Authors:  Richard Wu; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2021-05-10       Impact factor: 4.806

Review 2.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 3.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

4.  Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C.

Authors:  Quang T Le; Hae-Ki Min; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

5.  High degree of conservation of the multigene tryptase locus over the past 150-200 million years of mammalian evolution.

Authors:  Jenny M Reimer; Paul B Samollow; Lars Hellman
Journal:  Immunogenetics       Date:  2010-04-10       Impact factor: 2.846

6.  Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.

Authors:  Jonathan J Lyons; Xiaomin Yu; Jason D Hughes; Quang T Le; Ali Jamil; Yun Bai; Nancy Ho; Ming Zhao; Yihui Liu; Michael P O'Connell; Neil N Trivedi; Celeste Nelson; Thomas DiMaggio; Nina Jones; Helen Matthews; Katie L Lewis; Andrew J Oler; Ryan J Carlson; Peter D Arkwright; Celine Hong; Sherene Agama; Todd M Wilson; Sofie Tucker; Yu Zhang; Joshua J McElwee; Maryland Pao; Sarah C Glover; Marc E Rothenberg; Robert J Hohman; Kelly D Stone; George H Caughey; Theo Heller; Dean D Metcalfe; Leslie G Biesecker; Lawrence B Schwartz; Joshua D Milner
Journal:  Nat Genet       Date:  2016-10-17       Impact factor: 38.330

Review 7.  Tryptase as a polyfunctional component of mast cells.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

Review 8.  Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.

Authors:  Sarah C Glover; Melody C Carter; Peter Korošec; Patrizia Bonadonna; Lawrence B Schwartz; Joshua D Milner; George H Caughey; Dean D Metcalfe; Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-08-13       Impact factor: 6.248

9.  Mutational tail loss is an evolutionary mechanism for liberating marapsins and other type I serine proteases from transmembrane anchors.

Authors:  Kavita Raman; Neil N Trivedi; Wilfred W Raymond; Rajkumar Ganesan; Daniel Kirchhofer; George M Verghese; Charles S Craik; Eric L Schneider; Shilpa Nimishakavi; George H Caughey
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

10.  Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.

Authors:  Neil N Trivedi; Bani Tamraz; Catherine Chu; Pui-Yan Kwok; George H Caughey
Journal:  J Allergy Clin Immunol       Date:  2009-09-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.